Cargando…

Immunotherapy in Advanced Biliary Tract Cancers

SIMPLE SUMMARY: A new era has emerged in oncology in the last ten years with the development of immune therapies. However, single-agent immune therapy such as immune checkpoint inhibitors seems to have a limited clinical activity in biliary tract cancers and are still largely investigational, except...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boilève, Alice, Hilmi, Marc, Smolenschi, Cristina, Ducreux, Michel, Hollebecque, Antoine, Malka, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036747/ https://www.ncbi.nlm.nih.gov/pubmed/33805461 http://dx.doi.org/10.3390/cancers13071569

Ejemplares similares

Targetable Molecular Alterations in the Treatment of Biliary Tract Cancers: An Overview of the Available Treatments
por: Valery, Marine, et al.
Publicado: (2023)

Precision Medicine in Pancreatic Ductal Adenocarcinoma: The Impact of Targeted Therapies on Survival of Patients Harboring Actionable Mutations
por: Tarabay, Anthony, et al.
Publicado: (2023)

Molecular targeted therapy of BRAF-mutant colorectal cancer
por: Ducreux, Michel, et al.
Publicado: (2019)

Immunotherapy and Hepatocellular Cancer: Where Are We Now?
por: Valery, Marine, et al.
Publicado: (2022)

Implementing patient derived organoids in functional precision medicine for patients with advanced colorectal cancer
por: Cartry, Jérôme, et al.
Publicado: (2023)

Evolving Role of Immunotherapy in Advanced Biliary Tract Cancers
por: Kang, Sandra, et al.
Publicado: (2022)

Optimizing Patient Pathways in Advanced Biliary Tract Cancers: Recent Advances and a French Perspective
por: Neuzillet, Cindy, et al.
Publicado: (2023)

Biomarkers in Hepatobiliary Cancers: What Is Useful in Clinical Practice?
por: Boilève, Alice, et al.
Publicado: (2021)

Immunotherapy and Targeted Therapy for Advanced Biliary Tract Cancer: Adding New Flavors to the Pizza
por: Queiroz, Marcello Moro, et al.
Publicado: (2023)

Immunotherapy in Biliary Tract Cancers: Current Standard-of-Care and Emerging Strategies
por: Lo, Justin H., et al.
Publicado: (2023)

No evidence for changes in skeletal muscle mass or weight during first-line chemotherapy for metastatic colorectal cancer
por: Antoun, Sami, et al.
Publicado: (2019)

Combination Therapies for Advanced Biliary Tract Cancer
por: Zeng, Weifeng, et al.
Publicado: (2023)

mTOR Inhibitors in Advanced Biliary Tract Cancers
por: Wu, Chao-En, et al.
Publicado: (2019)

Toripalimab in advanced biliary tract cancer
por: Li, Wei, et al.
Publicado: (2022)

Quality of Life and Symptom Management in Advanced Biliary Tract Cancers
por: Hunter, Lindsay A., et al.
Publicado: (2021)

Current status of chemotherapy for the treatment of advanced biliary tract cancer
por: Sasaki, Takashi, et al.
Publicado: (2013)

Targeted Therapies in Advanced Biliary Tract Cancer: An Evolving Paradigm
por: Chakrabarti, Sakti, et al.
Publicado: (2020)

Advances in the systemic treatment of therapeutic approaches in biliary tract cancer
por: Mirallas, O., et al.
Publicado: (2022)

Immunotherapy for Biliary Tract Cancer in the Era of Precision Medicine: Current Knowledge and Future Perspectives
por: Ciardiello, Davide, et al.
Publicado: (2022)

Current Role and Future Perspectives of Immunotherapy and Circulating Factors in Treatment of Biliary Tract Cancers
por: Conci, Simone, et al.
Publicado: (2023)

Predicting immunotherapy outcomes in patients with MSI tumors using NLR and CT global tumor volume
por: Belkouchi, Younes, et al.
Publicado: (2022)

Immunotherapy in Biliary Tract Cancer: Worthy of a Second Look
por: Ricci, Angela Dalia, et al.
Publicado: (2020)

Immunotherapy in biliary tract cancers: Current evidence and future perspectives
por: Uson Junior, Pedro Luiz Serrano, et al.
Publicado: (2022)

Systemic treatment options for advanced biliary tract carcinoma
por: Xie, Changqing, et al.
Publicado: (2020)

Genomic alterations in biliary tract cancer predict prognosis and immunotherapy outcomes
por: Chen, Xiaofeng, et al.
Publicado: (2021)

IDH Inhibitors and Immunotherapy for Biliary Tract Cancer: A Marriage of Convenience?
por: Brandi, Giovanni, et al.
Publicado: (2022)

Current options and future directions of systemic therapy for advanced biliary tract cancer
por: Prete, Maria Giuseppina, et al.
Publicado: (2021)

Targeting BRAF-Mutant Biliary Tract Cancer: Recent Advances and Future Challenges
por: Rizzo, Alessandro, et al.
Publicado: (2020)

Chemotherapy for Biliary Tract Cancer in 2021
por: Sasaki, Takashi, et al.
Publicado: (2021)

Targeted Therapy for Biliary Tract Cancer
por: Furuse, Junji, et al.
Publicado: (2011)

Adjuvant therapy of biliary tract cancers
por: Kefas, Joanna, et al.
Publicado: (2023)

Main causes of death in advanced biliary tract cancer
por: Kimura‐Seto, Kana, et al.
Publicado: (2023)

Durvalumab: A Review in Advanced Biliary Tract Cancer
por: Fung, Simon, et al.
Publicado: (2023)

Targeting Angiogenesis in Biliary Tract Cancers: An Open Option
por: Simone, Valeria, et al.
Publicado: (2017)

Lacking Immunotherapy Biomarkers for Biliary Tract Cancer: A Comprehensive Systematic Literature Review and Meta-Analysis
por: Frega, Giorgio, et al.
Publicado: (2023)

Targeting Angiogenesis in the Era of Biliary Tract Cancer Immunotherapy: Biological Rationale, Clinical Implications, and Future Research Avenues
por: Schirizzi, Annalisa, et al.
Publicado: (2023)

Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review
por: Park, Joon Oh, et al.
Publicado: (2015)

Adjuvant treatment in biliary tract cancer
por: Palloni, Andrea, et al.
Publicado: (2019)

Robotic Surgery for Biliary Tract Cancer
por: Kone, Lyonell B., et al.
Publicado: (2022)

Neoadjuvant treatment of biliary tract cancer: state-of-the-art and new perspectives
por: Imperatori, Marco, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_uvkvjc8c2h32tc5v1kbl1j8hlo